AFTER a string of failed clinical trials, the HIV vaccine is going back to the drawing board.
“We were maybe on the wrong track,” said Anthony Fauci, director of the US , in a podcast produced by Science. In the journal, Fauci outlined NIAID’s plan to shift HIV resources away from clinical trials and back towards fundamental questions (Science, vol 321, p 530).
His report follows the cancellation on 17 July of a plan to test the latest generation of HIV vaccine on more than 8500 people. They were to be injected…
